Comparison between Cadsys IPO and Vanta Bioscience IPO.
Cadsys IPO is a SME Fixed Price IPO proposed to list at NSE SME while Vanta Bioscience IPO is a SME Fixed Price proposed to list at BSE SME.
| Cadsys IPO | Vanta Bioscience IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Saffron Capital Advisors Pvt.Ltd. | Inventure Merchant Banker Services Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | New Berry Capitals Pvt.Ltd. | Inventure Growth & Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Cadsys IPO is up to ₹13.94 Cr whereas the issue size of the Vanta Bioscience IPO is up to ₹7.17 Cr. The final issue price of Cadsys IPO is ₹70.00 per share and of Vanta Bioscience IPO is ₹50.00 per share.
| Cadsys IPO | Vanta Bioscience IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹70.00 per share | ₹50.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 3000 shares |
| Fresh Issue Size | 19,92,000 shares | 14,34,000 shares |
| Fresh Issue Size (Amount) | up to ₹13.94 Cr | up to ₹7.17 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 19,92,000 shares | 14,34,000 shares |
| Issue Size Total (Amount) | up to ₹13.94 Cr | up to ₹7.17 Cr |
Cadsys IPO opens on Sep 21, 2017, while Vanta Bioscience IPO opens on Sep 25, 2017. The closing date of Cadsys IPO and Vanta Bioscience IPO is Sep 25, 2017, and Sep 27, 2017, respectively.
| Cadsys IPO | Vanta Bioscience IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 21, 2017 | Sep 25, 2017 |
| Issue Close | Sep 25, 2017 | Sep 27, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Oct 04, 2017 | Oct 06, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Cadsys IPO P/E ratio is , as compared to Vanta Bioscience IPO P/E ratio of .
| Cadsys IPO | Vanta Bioscience IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹52.52 Cr. | ₹28.64 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Cadsys IPO Retail Individual Investors (RII) are offered 9,96,000 shares while in Vanta Bioscience IPO retail investors are offered 9,96,000 shares. Qualified Institutional Buyers (QIB) are offered in Cadsys IPO and in Vanta Bioscience IPO.
| Cadsys IPO | Vanta Bioscience IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,08,000 shares | 78,000 shares |
| QIB | ||
| NII | 9,96,000 shares | 7,17,000 shares |
| RII | 9,96,000 shares | 7,17,000 shares |
| Employee | ||
| Others | ||
| Total | 19,92,000 shares | 14,34,000 shares |
Cadsys IPO subscribed 3.17x in total, whereas Vanta Bioscience IPO subscribed 1.44x.
| Cadsys IPO | Vanta Bioscience IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.05x | 1.52x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.28x | 1.36x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 3.17x | 1.44x |
